DongKoo Bio & Pharma Co. Ltd. Capital Reinvestment Ratio
DongKoo Bio & Pharma Co. Ltd. capital reinvestment ratio. DongKoo Bio & Pharma Co. Ltd. (006620) has a Capital Reinvestment Ratio of 1.17x as of June 2026, meaning it reinvests 1% of its operating cash flow (₩4.46 Billion) in capital expenditures (₩5.21 Billion). Check cash flow reinvestment rate of DongKoo Bio & Pharma Co. Ltd. to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of DongKoo Bio & Pharma Co. Ltd. (2015–2024)
Capital reinvestment ratio of DongKoo Bio & Pharma Co. Ltd. from 2015 to 2024. This chart tracks DongKoo Bio & Pharma Co. Ltd.'s Capital Reinvestment Ratio across 9 annual periods. Also explore 006620 shareholders equity momentum to track the company's year-over-year net asset growth rate.
DongKoo Bio & Pharma Co. Ltd. Capital Reinvestment Ratio by Year (2015–2024)
DongKoo Bio & Pharma Co. Ltd. capital reinvestment ratio by year from 2015 to 2024. For the full cash flow conversion analysis, see how efficiently does DongKoo Bio & Pharma Co. Ltd. generate cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.47x | ₩17.34 Billion | ₩25.46 Billion | ▼ -67.0% |
| 2023 | 4.45x | ₩3.59 Billion | ₩15.97 Billion | ▲ +576.2% |
| 2022 | 0.66x | ₩16.82 Billion | ₩11.08 Billion | ▲ +176.3% |
| 2021 | 0.24x | ₩17.90 Billion | ₩4.27 Billion | ▼ -66.1% |
| 2020 | 0.70x | ₩7.49 Billion | ₩5.27 Billion | ▼ -18.7% |
| 2019 | 0.86x | ₩10.14 Billion | ₩8.77 Billion | ▲ +914.5% |
| 2017 | 0.09x | ₩9.51 Billion | ₩810.51 Million | ▼ -83.6% |
| 2016 | 0.52x | ₩12.59 Billion | ₩6.55 Billion | ▲ +55.9% |
| 2015 | 0.33x | ₩6.93 Billion | ₩2.32 Billion | — |